Referenser och mer information

1.         GBS 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736-1788. doi: 10.1016/S0140-6736(18)32203-7

2.         GBS 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-1222. doi: 10.1016/S0140-6736(20)30925-9

3.         Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459-2472. doi: 10.1093/eurheartj/ehx144

4.         Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952. doi: 10.1016/S0140-6736(04)17018-9

5.         GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795-820. doi: 10.1016/S1474-4422(21)00252-0

6.         Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, Thorand B, Giampaoli S, Brambilla P, Tunstall-Pedoe H, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019;394:2173-2183. doi: 10.1016/S0140-6736(19)32519-X

7.         NCD Risk Factor Collaboration. Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020;582:73-77. doi: 10.1038/s41586-020-2338-1

8.         Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111-188. doi: 10.1093/eurheartj/ehz455

9.         Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-3337. doi: 10.1093/eurheartj/ehab484

10.       Jaspers NEM, Blaha MJ, Matsushita K, van der Schouw YT, Wareham NJ, Khaw KT, Geisel MH, Lehmann N, Erbel R, Jockel KH, et al. Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. Eur Heart J. 2020;41:1190-1199. doi: 10.1093/eurheartj/ehz239

11. Uträknat med LIFE-CVD-skalan (se referens 10 ovan) och LDL-kolesterol 3,5 mmol/L.

12.       Gopalan C KE. Biology of Cardiovascular and Metabolic Diseases. Academic Press; 2022.

13. Npathett. Late complications of atherosclerosis [Illustration]. 2021. Wikimedia Commons, the free media repository. Uppdaterad senast 21 augusti 2022. Hämtad 6 mars 2023 via https://commons.wikimedia.org/w/index.php?title=File:Late_complications_of_atherosclerosis.PNG&oldid=469694743. Modifierad enligt Gopalan et al (12).

14. Läkemedelsverket (2023). Matvanor, hälsa & miljö. Senast granskad 2022-08-29. Tillgänglig via https://www.livsmedelsverket.se/matvanor-halsa--miljo (2023-07-03).

15. Blomhoff R, Andersen R, Arnesen EK, Christensen JJ, Eneroth H, Erkkola M, Gudanaviciene I, Halldorsson TI, Hoyer-Lund A, Lemming EW, et al. Nordic Nutrition Recommendations 2023: Integrating Environmental Aspects. Copenhagen: Nordic Council of Ministers; 2023. Tillgänglig via https://norden.diva-portal.org/smash/get/diva2:1769986/FULLTEXT02.pdf (2023-07-03).

16. Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Jr., Brehm BJ, Bucher HC. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:285-293. doi: 10.1001/archinte.166.3.285

17. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320-328. doi: 10.1093/ajcn/56.2.320